MSR101 Predicting Overall Survival of Immune-Checkpoint Inhibitors (ICIS): Which Distributions Are the Most Accurate? A Systematic Literature Review and Extrapolations of French Cost-Effectiveness Report Assessments
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1832
https://www.valueinhealthjournal.com/article/S1098-3015(22)04037-2/fulltext
Title :
MSR101 Predicting Overall Survival of Immune-Checkpoint Inhibitors (ICIS): Which Distributions Are the Most Accurate? A Systematic Literature Review and Extrapolations of French Cost-Effectiveness Report Assessments
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)04037-2&doi=10.1016/j.jval.2022.09.1832
First page :
Section Title :
Open access? :
No
Section Order :
11383